OSI Systems, Inc.
(NASDAQ: OSIS), a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, received clearance under Section 510(k) from the U.S. Food and Drug Administration to market the Blease900 Ventilator Series.
The Blease900 is integrated in the BleaseFocus Anesthesia System. With this clearance, Spacelabs Healthcare is expected to begin selling the new BleaseFocus Anesthesia System into the United States. This system provides an ideal solution for day surgery and small hospital markets which need high performance solutions that meet their requirement for compact size and value pricing.
“The Blease900 ventilator continues our long history of innovation in anesthesia ventilation, delivering versatility and truly Patient Centered Ventilation with advanced modes of ventilation,” said Deepak Chopra, OSI Systems CEO.
About OSI Systems, Inc.
OSI Systems, Inc. is a vertically integrated designer and manufacturer of specialized electronic system and components for critical applications in the homeland security, healthcare, defense and aerospace industries. We combine more than 30 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end product markets. For more information on OSI Systems Inc. or any of its subsidiary companies, visit
. News Filter: OSIS-G
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to the Company’s current expectations, beliefs, projections and similar expressions concerning matters that are not historical facts and are not guarantees of future performance.
Forward-looking statements involve uncertainties, risks, assumptions and contingencies, many of which are outside the Company’s control, that may cause actual results may differ materially from those described in or implied by any forward-looking statement.
All forward-looking statements are based on currently available information and speak only as of the date on which they are made.
The Company assumes no obligation to update any forward-looking statement made in this press release that becomes untrue because of subsequent events, new information or otherwise, except to the extent it is required to do so in connection with its ongoing requirements under Federal securities laws.
For a further discussion of these and other factors that could cause the Company’s future results to differ materially from any forward-looking statements, see the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended June 30, 2011 and other risks described in documents subsequently filed by the Company from time to time with the Securities and Exchange Commission.